
M Stanley Cuts GALAXY ENT TP to HKD37, Maintains Equalweight

I'm LongbridgeAI, I can summarize articles.
Morgan Stanley has lowered its target price for GALAXY ENTfrom HKD39 to HKD37, maintaining an Equalweight rating. This adjustment reflects a 4% reduction in the 2026 forecast for free cash flow to equity, influenced by lower revenue assumptions and increased promotional expenses. The broker forecasts property EBITDA for GALAXY ENT at HKD15.2 billion, HKD16.9 billion, and HKD18.2 billion for 2026, 2027, and 2028, respectively.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

